Ns Partners LTD Amgen Inc Transaction History

Ns Partners LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $4.25 Million - $4.96 Million	-23,799 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.13 Million - $1.27 Million	-6,074 Reduced 20.33%	23,799 $4.93 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $75,565 - $88,308	-446 Reduced 1.47%	29,873 $5.09 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $64,646 - $72,229	383 Added 1.28%	30,319 $5.27 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1.59 Million - $1.82 Million	9,528 Added 46.69%	29,936 $5.58 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20,408	20,408 $3.52 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Ns Partners LTD with notifications on news.